Category Archives: ALS Newsroom
Centaur Trial (AMX0035): Longterm Survival Data
MOFF attended the NEALS webinar hosted by Dr. Sabrina Paganoni and Dr. Merit Cudkowicz on
Oct
Prop 14 (CA)
What’s all the buzz about Proposition 14? Why is the scientific community encouraging everyone to vote
Oct
Novus Acquisition of Anelixis
The Martha Olson-Fernandez Foundation (MOFF) was very excited to hear that Novus Therapeutics had finalized
Oct
CRISPR and ALS
Brief Overview CRISPR is a highly specific and efficient genome editing technology. CRISPR facilitates the
Jul
ALS/MND International Alliance Scientific Advisory Council Meeting
MOFF attended the ALS/MND International Alliance Scientific Advisory Council Meeting on June 17th (at 4
Jun
The Political Front: National ALS Advocacy Conference
The National ALS Advocacy Conference (May 26, 2020 – June 3, 2020) The National ALS
May
ALS Biomarker Panel at the Society for Brain Mapping and Therapeutics Conference
15–17 March 2019 SBMT 16th Annual Congress Los Angeles Convention Center in LA FLYER The
Mar
2019 California ALS Research Summit
Day 1 Takeaways: 1. Whole genome sequencing (WGS) analysis projects are being undertaken by the
Jan